-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

602. Myeloid Oncogenesis: Basic: Poster III

Symposia: Myeloid Oncogenesis: Basic Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Theresa Eifert, MSc1*, Tina M. M Schnoeder, PhD1*, Chen-Jen Hsu, MSc1*, Alicia L Becker1*, Qirui Zhang, PhD1*, Juliane Mohr, PhD2*, Stephanie Frey3*, Sebastian Scholl, MD4*, Lars Bullinger, MD5, Steven W Lane, MD, PhD6 and Florian H. Heidel, MD1,7

1Klinik und Poliklinik für Innere Medizin C, Universitätsklinikum Greifswald, Greifswald, Germany
2Institute of Molecular and Clinical Immunology, Otto-von-Guericke-University Medical Center, Magdeburg, Germany
3Department of Hematology and Oncology, Otto-von-Guericke-University Medical Center, Magdeburg, Germany
4Department of Internal Medicine II, Hematology and Oncology, University Hospital Jena, Jena, Germany
5Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine Berlin, Berlin, Germany
6Cancer Program, Queensland Institute of Medical Research, Brisbane, Australia
7Fritz-Lipmann Institute, Leibniz Institute on Aging, Jena, Germany

Sumiko Takao, MD, PhD1*, Victor Morell, BS1*, Fiona C. Brown, PhD2*, Richard Koche, PhD3* and Alex Kentsis, MD, PhD4,5,6

1Molecular Pharmacology Program, Sloan Kettering Institute and Tow Center for Developmental Oncology, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
2Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
3Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY
4Tow Center for Developmental Oncology, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
5Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY
6Departments of Pharmacology and Physiology & Biophysics, Weill Cornell Medical College, Cornell University, New York, NY

Gabriela Krivdova, PhD1*, Brian Yee, MS2*, Stefan Aigner, PhD2*, Martino Gabra3*, Alexander Shishkin4*, Long Nguyen5*, Jessica L McLeod6*, Leah Carley7*, Leonardo Salmena8*, Lorien Shakib1*, Mark D. Minden1,9*, Eric L Van Nostrand, PhD10*, Gene W. Yeo, PhD2*, Eric R. Lechman, PhD1 and John E. Dick, PhD11,12

1Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
2Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA
3Pharmacology, University of Toronto, Tornto, Canada
4Eclipse Bioinnovations, San Diego, CA
5Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom
6Phillip Orsino Cell Processing Laboratory, Princess Margaret Cancer Centre, Toronto, ON, Canada
7Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
8Pharmacology, University of Toronto, Toronto, Canada
9Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada
10University of California, San Diego, La Jolla, CA
11Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
12University Health Network, Toronto, ON, Canada

Anna LW Huskey, PhD1, Pandurang Kolekar, Ph.D2*, Tamara Westover, BS3, Jing Ma, PhD3*, Michael P Walsh, PhD3*, Masayuki Umeda, MD3*, Guangchun Song3*, Yanling Liu, PhD2*, Quang Tran, PhD2, Xiaotu Ma, PhD4* and Jeffery M. Klco, MD, PhD3

1Department of Pathology, St. Jude Children's Research Hospital, Cordova, TN
2Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN
3Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
4St. Jude Children's Research Hospital, Memphis, TN

Angela Mo, PhD1*, Hayle Kincross, BSc1,2*, Xuan Wang, MSc1*, Linda Ya-Ting Chang, PhD1*, Gerben Duns, PhD1*, Harwood Kwan1*, Tammy Lau1*, Rod Docking, MSc, PhD1, Se-Wing Grace Cheng1*, Shujun Huang, PhD1*, Nadia Gharaee, MSc1*, Elijah Willie, MSc1*, Jihong Jiang, PhD1*, Jeremy Parker, PhD1*, Josh Bridgers1*, Gregg Morin, PhD1,2* and Aly Karsan, MD2,3

1Canada's Michael Smith Genome Sciences Centre, Vancouver, BC, Canada
2University of British Columbia, Vancouver, BC, Canada
3BC Cancer Research Centre, Canada's Michael Smith Genome Sciences Centre, Vancouver, BC, Canada

Jane J Xu, PhD1*, Besmira Alija1*, Stephanie Braunstein1*, John Pantazi1*, Varun S Sudunagunta, BA2, Robert L. Bowman, PhD3 and Aaron D Viny, MD, MS4

1Division of Hematology and Oncology, Department of Medicine, Columbia University, New York, NY
2Vagelos College of Physicians & Surgeons, Columbia University, NEW YORK, NY
3Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
4Columbia Stem Cell Initiative, Columbia University, New York, NY

Lianjun Zhang, PhD1*, Le Xuan Truong Nguyen, PhD1*, Wei-Kai Hua, PhD1*, Yinghui Zhu, PhD1*, Ying-Chieh Chen, PhD1*, Xin He, MD2*, Man Li, PhD1*, Yu-Hsuan Fu, M.S.1*, Haojie Dong, PhD1*, Bin Zhang, PhD1, Ling Li, PhD3, Jeremy Stark4*, Guido Marcucci, MD5 and Ya-Huei Kuo, PhD1

1Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
2Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope National Medical Center, Monrovia, CA
3Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
4Department of Cancer Genetics and Epigenetics, Beckman Research Institute - City Of Hope, Duarte, CA
5Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

Liana Valin, BS1*, Joice Kanefsky, BSc2, Esteban Martinez, BSc2*, Jacklyn Huhn, BS3*, Orsola Di Martino, PhD4, Stephen M. Sykes, PhD5 and Judith Sokei, BS, MS6*

1Department of Pediatrics, Washington University in Saint Louis, Saint Louis, MO
2Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA
3Lewis Katz School of Medicine, Temple University Health System, Philadelphia, PA
4Department of Medicine, Division of Oncology, Washington University, Saint Louis, MO
5Department of Pediatrics, Washington University, Saint Louis, MO
6Division of Biology and Biomedical Sciences, Washington University of Saint Louis, Saint Louis, MO

Marlise L Guerrero Schimpf, PhD, Courtney C. Sparger, BS, Hsuan-Ting Huang, PhD, Dean Wade, BA* and Maria Ken E. Figueroa, MD

Department of Human Genetics, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL

Douglas RA RA Silveira, MD, PhD1*, Prodromos Chatzikyriakou, PhD2*, Maria del Pilar Casares Alaez2*, Sarah Mackie2*, Roan Hulks2*, Olena Yavorska, PhD3*, Paulina Siejka-Zielinska4*, Marlen Metzner, MSc5*, Alastair Smith6*, Batchimeg Usukhbayar5*, Virginie Penard-Lacronique, PhD7*, Chunxiao Song4*, Anita K. Gandhi, PhD8, Maroof Hasan, MD8*, Paresh Vyas, DPhil, FRCP, FRCPath, MRCP, MRCPath5, Thomas A. Milne6, Skirmantas Kriaucionis, PhD9* and Lynn Quek, MBBCh, DPhil, MRCP (UK), FRCPath2,10*

1School of Cancer and Pharmaceutical Sciences, King's College London, London, ENG, United Kingdom
2School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom
3Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
4University of Oxford, Oxford, United Kingdom
5MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
6MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, NIHR Oxford Biomedical Research Centre Haematology Theme, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
7INSERM U1170, Universit, Villejuif, France
8Translational Medicine Hematology, Bristol Myers Squibb, Summit, NJ
9Ludwig Institute for Cancer Research, University of Oxford, Oxford, United Kingdom
10Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom

Olivia Arnold1,2*, Luke Christiansen, Ph.D.1,2*, Jesus Izaguirre-Carbonell, Ph.D.2*, Theresa Bluemn, PhD3*, Mark Wunderlich, MS4* and Nan Zhu, PhD1,2

1Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI
2Blood Research Institute, Versiti, Milwaukee, WI
3Versiti Blood Research Institute, Milwaukee
4Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Deirdra Venney, BSc1*, Graeme M Greenfield, BA, BMBCh, MRCP, FRCPath2*, Lauren V Cairns, PhD, BSc1*, Paul Strain, MSc, BSc3*, Áine E McGill2*, Jonathan J Morgan, BSc, MRes, PhD2*, Róisín M McAvera, PhD2*, Fatemeh Mirzadeh, PhD2*, Yaser Atlasi, PhD2*, Adone Mohd-Sarip, PhD2* and Ken I Mills, BSc, PhD, FRCPath2

1Queen's University Belfast, Belfast, NI, United Kingdom
2Queen's University Belfast, Belfast, United Kingdom
3Queen's University Belfast, Omagh, NI, United Kingdom

Junhua Lyu, PhD1*, Yuxuan Liu, PhD1*, Yuannyu Zhang, PhD1*, Feng Cai, PhD1*, Giovanni A. Botten1*, Hui Cao1*, Pranita Kaphle1*, Ralph J Deberardinis, MD, PhD1,2* and Jian Xu, PhD1

1Children’s Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX
2Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX

Marlon Arnone1*, Elsa Görsch2*, Simone Pöschel2*, Anna Stanger2*, Saskia Rudat2* and Claudia Lengerke, MD3

1Internal Medicin 2, Tuebingen, BW, Germany
2Internal Medicin 2, Tübingen, Germany
3Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany

Yasuo Kubota, MD, PhD1*, Laila Terkawi2*, Carmelo Gurnari, MD2, Juraj Bodo, PhD3*, Naomi Kawashima, MD, PhD2*, Mai Aly, MD, BSc, MS2*, Arda Durmaz2*, Minako Mori, MD, PhD2*, BEN Ponvilawan, MD2*, Tariq Kewan, MD2*, Waled Bahaj, MD2, Valeria Visconte, PhD2, Heesun J. Rogers, MD3, Torsten Haferlach, MD4 and Jaroslaw P. Maciejewski, MD, PhD, FACP5

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Beachwood, OH
2Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
3Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH
4MLL Munich Leukemia Laboratory, Munich, Germany
5Translational Hematology and Oncology Research, Cleveland Clinic Foundation/ Taussig Cancer Institute, Cleveland, OH

Andrew J. Monteith, PhD1,2*, Haley E. Ramsey, PhD, MSc2,3, Dalton Greenwood4*, Maria P. Arrate, MSc2*, Londa Fuller, LVMT2*, Agnieszka E. Gorska, MSc2*, Alexander J. Silver, BA5, Donovan J. Brown, BS2*, Sarah D. Olmstead2*, Jackson Watke2*, Matthew J. Stubbs, MBBS, MRCP, FRCPath6, Jeffrey C. Rathmell7,8* and Michael R. Savona, MD2,9,10,11

1Cancer Biology Program, Vanderbilt University Medical Center, Nashville, TN
2Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
3Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN
4Vanderbilt Center for Immunobiology, Departments of Pathology, Microbiology, and Immunology, Cancer Biology, Vanderbilt University Medical Center, Nashville, TN
5Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN
6Incyte Corporation, Wilmington, DE
7Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville
8Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN
9Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN
10Vanderbilt University School of Medicine, Nashville, TN
11Cancer Biology Program, Vanderbilt University, Nashville, TN

Judith S. Hecker1*, Jennifer Rivière1*, Mark van der Garde1*, Michèle C. Buck1*, Rupert Öllinger2*, Florian Bassermann1,3*, Bernd Giebel4*, Robert A.J. Oostendorp1, Roland Rad2* and Katharina S. Goetze1

1Department of Medicine III, Klinikum rechts der Isar, Technical University Munich (TUM), Munich, Germany
2Institute of Molecular Oncology and Functional Genomics, Technical University Munich (TUM), Munich, Germany
3Center for Translational Cancer Research (TranslaTUM), TUM School of Medicine, Technical University of Munich (TUM), Munich, Germany
4Institute for Transfusion Medicine, University Hospital Essen, Essen, Germany

Masami Ohzu, MD1*, Kazutoshi Ebisawa, MD, PhD2*, Ken Morita, MD, PhD2*, Yosuke Masamoto, MD, PhD3 and Mineo Kurokawa, MD, PhD4

1Department of Hematology & Oncology, The University of Tokyo, Bunkyo-ku, TKY, Japan
2The University of Tokyo, Bunkyo-ku, Japan
3Department of Hematology and Oncology, The University of Tokyo Hosiptal, Tokyo, Japan
4Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

Shuanghong Zhu1*, Chen Mei2*, Yuxia Wang3*, Jie Jin, PhD4, Jie Sun, PhD5* and Hongyan Tong, MD, PhD6*

1the first affiliated hospital of zhejiang university, hangzhou, China
2Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
3The First Affiliated Hospital, Zhejiang University School of Medicine,, hangzhou, China
4Department of Hematology, The First Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
5Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
6Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Jiajia Pan1*, Jie Jin, M.D., Ph.D.2,3, Yungui Wang, Ph.D.4*, Shujuan Huang5*, Wenwen Wei6*, Shihui Mao7*, Qing Ling8*, Chenying Li1* and Jinghan Wang, MD, PhD4*

1First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, China
2The First Affiliated Hospital, Zhejiang University of Medicine, Hangzhou, China
3Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, Zhejiang, PR China, Hangzhou, China
4Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
5Department of Hematology, the First Affiliated Hospital of University of Science and Technology of China, Hefei, China
6Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China., Hangzhou, China
7First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, Arizona, CHN
8the fisrt affliated hospital,Zhejiang university,school of medicine, Hangzhou, China

Matthew R.M. Jotte1*, Henna S. Nam2*, Bonnie Hu2*, Tanner C. Martinez1*, Saira Khan, MS3,4*, Ningfei An, PhD3,4*, Angela Stoddart, PhD4 and Megan E. McNerney, MD, PhD3,4,5

1Interdisciplinary Scientist Training Program, University of Chicago, Chicago, IL
2University of Chicago, Chicago, IL
3Department of Pediatrics, section of Hematology/Oncology, University of Chicago, Chicago, IL
4Department of Pathology, University of Chicago, Chicago, IL
5University of Chicago Medicine Comprehensive Cancer Center, University of Chicago, Chicago, IL

Alissa Oakes, BS1*, Anna D Chorzalska, PhD2*, Dennis M Bonal, MSc, BSc3*, John L Reagan, MD4 and Patrycja M Dubielecka, PhD5

1Signal Transduction Lab, Division of Hematology-Oncology, Rhode Island Hospital and Warren Alpert Medical School at Brown University, Providence, RI
2Signal Transduction Lab, Division of Hematology-Oncology,, Rhode Island Hospital and Warren Alpert Medical School at Brown University, Providence, RI
3Signal Transduction Lab, Division of Hematology-Oncology, Rhode Island Hospital and Warren Alpert Medical School at Brown University, Douglas, MA
4Division of Hematology/Oncology, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI
5Division of Hematology-Oncology, Warren Alpert Medical School of Brown University/Rhode Island Hospital, Providence, RI

Geethu Emily Thomas, PhD, MSc, BSc1, Kazem Nouri, PhD2*, Rose Hurren, BSc1*, Yongran Yan, MSc3*, Neil MacLean1*, Yulia Jitkova, PhD1*, Li Ma2*, Xiaoming Wang4*, Chaitra Sarathy, PhD1*, Andrea Arruda, MSc5*, Mark D. Minden, MD, PhD6, Vito Spadevecchio, B.A7* and Aaron D. Schimmer, MD, PhD6

1Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
2Princess Margaret Cancer Research, Toronto, ON, Canada
3Princess Margaret Cancer Center, University Health Network, Toronto, ON, Canada
4Princess Margaret Cancer Research, University Health Network, Toronto, ON, Canada
5University Health Network, Toronto, ON, Canada
6Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
7Interlinked Therapeutics LLC, Portland, OR

Eline J.M. Bertrums1,2,3*, Sjors Middelkamp1,2*, Inge M. van der Werf1,2*, Freek Manders, MSc1,2*, Arianne M. Brandsma, PhD2*, Niels M. Groenen1,2*, Mark Verheul1,2*, Markus J. van Roosmalen1,2*, C. Michel Zwaan, Prof. MD, PhD2,3*, Marry M. van den Heuvel-Eibrink, MD2,4, Bianca F. Goemans, MD, PhD2 and Ruben Van Boxtel, PhD1,2*

1Oncode Institute, Utrecht, Netherlands
2Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
3Department of Pediatric Oncology, Erasmus Medical Center - Sophia Children's Hospital, Rotterdam, Netherlands
4Utrecht University, Utrecht, Netherlands

Yang Li1*, Ziheng Xu, BS1*, Ryan B Day, MD, PhD2, Yiling Mi1*, Petra Erdmann-Gilmore1*, R. Reid Townsend, MD, PhD1* and Timothy J. Ley, MD2

1Washington University in St. Louis School of Medicine, Saint Louis, MO
2Department of Medicine, Division of Oncology, Section of Stem Cell Biology, Washington University in St. Louis School of Medicine, Saint Louis, MO

Mark Hartmann, PhD1,2*, Ling Hai, PhD3*, Joschka Hey, PhD4*, Maximilian Schönung1,2,5*, Valentin Maurer, B.Sc.1,2*, Jovana Rajak6*, Sina Staeble, PhD1,2, Jens Langstein, PhD1,2*, Katharina Bauer7*, Mariam Hakobyan, M.Sc.1*, Laura Jardine, PhD8*, Sheila Bohler, PhD6*, Dominik Vonficht, MSc5,9,10*, Abdul-Habib Maag11*, Dirk Lebrecht, PhD12*, Kathrin M. Bernt, MD13, Roland Roelz, MD14*, Tobias Boch, MD15*, Eleonora Khabirova, PhD16*, Pavlo Lutsik, PhD4*, Oliver Stegle, PhD17,18,19*, Simon Haas, PhD10,20,21,22*, Muzlifah Haniffa, PhD23*, Sam Behjati, PhD24*, Jan-Philipp Mallm, PhD7*, Christian Buske, MD11, Stefan Fröhling, MD2,25,26, Christoph Plass, PhD4*, Charlotte M. Niemeyer6,26, Christian Flotho, MD6,26*, Marc Jan Bonder, PhD17,18,19*, Miriam Erlacher, MD, PhD12,26*, Matthias Schlesner, PhD27* and Daniel B. Lipka, MD1,28

1Division of Translational Medical Oncology, Section Translational Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany
2National Center for Tumor Diseases (NCT), Heidelberg, Germany
3Department of Neurology and Neurooncology, University Hospital Heidelberg, Heidelberg, Germany
4Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany
5Faculty of Biosciences, Heidelberg University, Heidelberg, Germany
6Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University of Freiburg, Faculty of Medicine, Medical Center, Freiburg, Germany
7Single Cell Open Lab, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany
8Biosciences Institute, Newcastle University, Newcastle Upon Tyne, GBR
9Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany
10Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany
11Institute of Experimental Cancer Research, University Hospital of Ulm, Ulm, Germany
12Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany
13Pediatric Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
14Department of Neurosurgery, University of Freiburg, Faculty of Medicine, Medical Center, Freiburg, Germany
15Department of Hematology and Oncology, Heidelberg University, University Hospital Mannheim, Mannheim, Germany
16Wellcome Sanger Institute, Hinxton, United Kingdom
17Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
18Division of Computational Genomics and Systems Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany
19European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, European Molecular Biology Laboratory (EMBL), Hinxton, United Kingdom
20Berlin Institute of Health (BIH), Charité – Universitätsmedizin Berlin, Berlin, Germany
21Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrück Center in the Helmholtz Association, Berlin, Germany
22Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
23Biosciences Institute, Newcastle University, Newcastle upon Tyne, ENG, United Kingdom
24Wellcome Sanger Institute, Hinxton, ENG, United Kingdom
25Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
26German Cancer Consortium (DKTK), Heidelberg, Germany
27Faculty of Applied Computer Sciences, Biomedical Informatics, Data Mining and Data Analytics, Augsburg University, Augsburg, Germany
28National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany

Hannah Lawson1*, James Holt-Martyn2*, Vilma Dembitz1*, Jozef Durko1*, Yuka Kabayama3*, Lydia Wang1*, Louie Van De Lagemaat1*, Louis Dubusse1*, Laura Alunno1*, Amelie Guitart4*, Jürg Schwaller, MD5, Paolo Gallipoli, MD1, Dónal O'Carroll3*, Christopher Schofield2* and Kamil Kranc1*

1Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
2University of Oxford, Oxford, United Kingdom
3University of Edinburgh, Edinburgh, United Kingdom
4Université De Bordeaux, Bordeaux, FRA
5University Children's Hospital Basel, Department of Biomedicine, University of Basel, Basel, Switzerland

Juan M. Barajas, PhD, Sherif Abdelhamed, PhD, Tamara Westover, BS*, Masayuki Umeda, MD*, Ryan Hiltenbrand, MS*, Bright Arthur, MS*, Reethu Krishnan*, Michael P Walsh, PhD*, Jing Ma, PhD* and Jeffery M. Klco, MD, PhD

Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN

Xinyue Zhou1*, Steven Moreira, PhD2*, Hong Wang, PhD3*, Pengcheng Zhang1*, Yang Zhou, PhD4*, Ravi Bhatia, MD1, Chunliang Li, PhD5, Kristin Hope, PhD2 and Rui Lu, PhD6

1Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham
2Department of Medical Biophysics, University of Toronto, Toronto, Canada
3St. Jude Children's Research Hospital, Memphis
4Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham
5St. Jude Children's Research Hospital, Memphis, TN
6Division of Hematology and Oncology, Department of Medicine, University of Alabama At Birmingham, Birmingham, AL

Gabriel Levy, MD1,2,3*, Nicolas Papadopoulos2,3,4*, Christian Pecquet, PhD1,2,3*, Jean-Philippe Defour, BPharm, PhD1,2,3*, Emilie Leroy, PhD1,2,3*, Nabih Maslah, PharmD, PhD5,6*, Bruno Cassinat, PharmD, PhD5,6, Steven Smith, PhD7* and Stefan N Constantinescu, MD1,2,3,8

1de Duve Institute, Université catholique de Louvain, Brussels, Belgium
2Ludwig Institute for Cancer Research, Brussels, Belgium
3WELBIO (Wallon Excellence in Life Sciences and Biotechnology), Brussels, Belgium
4de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
5INSERM UMR 1131, Institut de Recherche Saint-Louis, Paris, France
6AP-HP, Hopital Saint-Louis, Laboratoire de Biologie Cellulaire, Paris, France
7Department of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY
8Nuffield Department of Medicine, Ludwig Institute for Cancer Research, Oxford University, Oxford, United Kingdom

Chenwei Yang*, Li Gao, MD*, Jing Ling, MD*, Hu Liu*, Qi Ji*, Minyuan Liu*, Yongping Zhang*, Shaoyan Hu, MD, PhD and Yuanyuan Tian*

Department of Pediatric Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China

Anita Ng1*, Yuhong Ma, PhD2, Yuri Pekarsky, PhD3*, Francesca Lovat, PhD4*, Frank Di Caro5*, Esha Sharma6*, Lita Crichton5*, Britta Will, PhD7, Carlo M. Croce, MD4 and Nicholas Chiorazzi, MD1

1Karches Center for Oncology Research, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY
2Albert Einstein College of Medicine, Bronx, NY
3OSU, Columbus, OH
4Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH
5Karches Center for Oncology Research, The Feinstein Institute of Medical Research, Manhasset, NY
6The Feinstein Institute for Medical Research, Manhasset, NY
7Division of Hematologic Malignancies, Department of Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY

Nicolas Niklaus, PhD1*, Magali Humbert, PhD2, Bruce E. Torbett, PhD3 and Mario P. Tschan, PhD4

1Institute of Pathology, University Bern, Bern, Bern, Switzerland
2HemostOD SA, Lausanne, Switzerland
3Department of Pediatrics, School of Medicine, University of Washington, Seattle, Seattle, WA
4University of Bern, Bern, Switzerland

*signifies non-member of ASH